HIV

Syndicate content

Effective TB vaccine for HIV-positive people

UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials.

Get the full story...

Scripps research team sheds light on immune system suppression

Work could aid development of new treatments for such conditions as HIV, measles, and tuberculosis

Get the full story...

Better Outcomes in HIV-Infected Adults

A study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that HIV-infected patients taking the antiretroviral drug efavirenz were more likely to adhere to treatment and less likely to experience virologic failure and death compared to patients taking nevirapine.

Get the full story...

New research on family-based HIV prevention

Researchers from the Bradley Hasbro Children's Research Center (BHCRC) presented exciting new research today at the National Institute of Mental Health (NIMH) Annual International Research Conference on the Role of Families in Preventing and Adapting to HIV/AIDS.

Get the full story...

African-American blogs offer key health communications tool

Blogs allow African Americans to discuss HIV and AIDS in an unfiltered way that is both public and private, according to a Penn State researcher, and this exploration may lead to another way to distribute health messages to the African American community.

Get the full story...

Novel therapeutic targets for HIV

The Salk Institute for Biological Studies and Burnham Institute for Medical Research today announced 295 host cell factors that are involved in human immunodeficiency virus (HIV) infection.

Get the full story...

Urbanization in Africa at dawn of 20th century marked outbreak of HIV

New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, suggesting that growing urbanization in colonial Africa set the stage for the HIV/AIDS pandemic.

Get the full story...

Anti-obesity drugs may be effective against flu, hepatitis and HIV

Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.

Get the full story...

Key HIV protein, open door for more powerful AIDS drugs

University of Michigan scientists have provided the most detailed picture yet of a key HIV accessory protein that foils the body's normal immune response.

Get the full story...

Why some primates can live with HIV and not progress to AIDS

Key differences in immune system signaling and the production of specific immune regulatory molecules may explain why some primates are able to live with an immunodeficiency virus infection without progressing to AIDS-like illness, unlike other primate species, including rhesus macaques and humans, that succumb to disease.

Get the full story...

Vaginal proteins in HIV-resistant prostitutes suggest new prevention measures

Researchers in Canada report discovery of unusual proteins in a small group of Kenyan sex workers that appear to be associated with resistance to infection with HIV, the virus that causes AIDS.

Get the full story...

Gap in HIV testing knowledge among college students

Most college students understand how they can prevent the transmission of HIV but are less knowledgeable about HIV testing, according to a new University of Georgia study.

Get the full story...